California pulls its multi-million contract with Walgreens over the company’s recent abortion pill decision. Lobbying group PhRMA and community health centers unite in calls for reforms to the 340B program. And, the manufacturer of a treatment to prevent preterm births pulls its drug from the market following scrutiny. That’s coming up on today’s episode of Gist Healthcare Daily.

Hosted on Acast. See acast.com/privacy for more information.